|Articles|June 28, 2023

DIA 2023: PALADIN Brings Patient Advocacy and Industry Together

New pre-competitive, disease-agnostic Consortium hopes to optimize advocacy group-industry collaboration to ultimately accelerate the pace of medicines development.

In this interview, Vicky DiBiaso, Global Head, Patient Informed Development & Health Value Translation at Sanofi and Kenneth Getz, Executive Director/Professor, Tufts CSDD and Founder/Board Chair, CISCRP, discuss the formation, mission and goals for the newly-launched Patient Advocacy Leaders And Drug (Development) Industry Network or PALADIN.

Read more on PALADIN's formation.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content